oxazoles has been researched along with leflunomide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartlett, RR; Langer, KH; Schleyerbach, R; Sitter, T; Thoenes, GH | 1 |
| Hirschelmann, R; Schade, R | 1 |
| Bartlett, RR | 1 |
| Buyniski, JP; Gylys, JA; Pasternak, RD; Siminoff, P; Wadopian, NS; Wright, RN | 1 |
| Bartlett, RR; Popovic, S | 1 |
| Bartlett, RR; Schleyerbach, R | 1 |
6 other study(ies) available for oxazoles and leflunomide
| Article | Year |
|---|---|
Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Autoimmune Diseases; Basement Membrane; Cyclosporins; Isoxazoles; Kidney Tubules; Leflunomide; Nephritis, Interstitial; Oxazoles; Rats; Rats, Inbred BN | 1989 |
6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Indans; Indenes; Inflammation; Isoxazoles; Leflunomide; Oxazoles; Rats; Sulfanilamides | 1988 |
Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; B-Lymphocytes; Cyclophosphamide; Cyclosporins; Female; Immune System; Isoxazoles; Leflunomide; Luminescent Measurements; Lymphocyte Activation; Mice; Mitogens; Oxazoles; Prednisolone; T-Lymphocytes | 1986 |
Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Cyclosporins; Hypersensitivity, Delayed; In Vitro Techniques; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Rats; Rats, Inbred Lew | 1987 |
Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Oxazoles | 1986 |
Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Cyclophosphamide; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Radiography; Rats; Rats, Inbred Lew | 1985 |